Skip to main content
Clinical Trials/NCT04455412
NCT04455412SuspendedNot Applicable

Laser Assisted ICSI; Has it Role Whatsoever? Does it Affect the ICSI Outcome Positively?1

Royal Fertility Center, Egypt2 sites in 1 country120 target enrollmentStarted: February 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Suspended
Sponsor
Enrollment
120
Locations
2
Primary Endpoint
Clinical pregnancy rate

Study Overview

Brief Summary

laser-assisted ICSI (LA-ICSI) was described to be a new method combining a less invasive ICSI technique with assisted hatching.This procedure is usually used for MII oocytes possessing oolemma breakage difficulties, but why not using it for even normal Oocytes?!. Especially because data indicated that in addition to an improved oocyte survival, this new approach increases the hatching rate in vitro. But since it is still debatable that such a small opening might impair the hatching process, so modified zona thinning technique was proposed for more embryo safety.

Detailed Description

This study aims to compare the LA- ICSI by drilling a micro hole (LAD-ICSI) and modified LA-ICSI by zona pellucida thinning (LAT-ICSI) with conventional ICSI in order to effectively assess whether this approach can be applied routinely to improve ICSI outcome.

One arm study divided into three interventions; Conventional ICSI (control group) was compared with LAD-ICSI (Study group 1) and LAT- ICSI (study group 2) in sibling oocytes.

The rates of maturation, fertilization, Devision, Blastulation and good quality blastulation rates were assessed in the three groups

Cases were randomly selected for embryo transfer from the three groups,Then chemical pregnancy and clinical pregnancy rates were compared between the three groups.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
20 Years to 37 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients aged from 20 years old to 37 years old
  • good res-ponders
  • gives more than 15 oocytes
  • endometrial thickness more than 9 mm

Exclusion Criteria

  • poor res-ponders
  • severe oligoasthinozoospermia of male partners
  • testicular samples
  • Poor quality oocytes

Outcomes

Primary Outcomes

Clinical pregnancy rate

Time Frame: three-four weeks after embryo transfer

confirmed by sac observation using ultrasound

Secondary Outcomes

  • Blastulation rate(5 days later after ICSI procedure)
  • Hatching rate(5 days later after ICSI procedure)

Investigators

Sponsor
Royal Fertility Center, Egypt
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Laser Assisted ICSI; Has it Role... | Clinical Trial